High frequency of alternative splicing variants of the oncogene Focal Adhesion Kinase in neuroendocrine tumors of the pancreas and breast / 医学前沿
Frontiers of Medicine
; (4): 907-923, 2023.
Article
en En
| WPRIM
| ID: wpr-1010812
Biblioteca responsable:
WPRO
ABSTRACT
The characteristic genetic abnormality of neuroendocrine neoplasms (NENs), a heterogeneous group of tumors found in various organs, remains to be identified. Here, based on the analysis of the splicing variants of an oncogene Focal Adhesion Kinase (FAK) in The Cancer Genome Atlas datasets that contain 9193 patients of 33 cancer subtypes, we found that Box 6/Box 7-containing FAK variants (FAK6/7) were observed in 7 (87.5%) of 8 pancreatic neuroendocrine carcinomas and 20 (11.76%) of 170 pancreatic ductal adenocarcinomas (PDACs). We tested FAK variants in 157 tumor samples collected from Chinese patients with pancreatic tumors, and found that FAK6/7 was positive in 34 (75.6%) of 45 pancreatic NENs, 19 (47.5%) of 40 pancreatic solid pseudopapillary neoplasms, and 2 (2.9%) of 69 PDACs. We further tested FAK splicing variants in breast neuroendocrine carcinoma (BrNECs), and found that FAK6/7 was positive in 14 (93.3%) of 15 BrNECs but 0 in 23 non-NEC breast cancers. We explored the underlying mechanisms and found that a splicing factor serine/arginine repetitive matrix protein 4 (SRRM4) was overexpressed in FAK6/7-positive pancreatic tumors and breast tumors, which promoted the formation of FAK6/7 in cells. These results suggested that FAK6/7 could be a biomarker of NENs and represent a potential therapeutic target for these orphan diseases.
Palabras clave
Texto completo:
1
Banco de datos:
WPRIM
Asunto principal:
Oncogenes
/
Neoplasias Pancreáticas
/
Neoplasias de la Mama
/
Empalme Alternativo
/
Tumores Neuroendocrinos
/
Carcinoma Ductal Pancreático
/
Proteína-Tirosina Quinasas de Adhesión Focal
/
Proteínas del Tejido Nervioso
Límite:
Female
/
Humans
Idioma:
En
Revista:
Frontiers of Medicine
Año:
2023
Tipo del documento:
Article